Ongoing clinical trials in lung cancer

European Journal of Surgical Oncology

Volumn 22, Issue 1, 1996, Pages 4-9

  Giaccone, Giuseppe ^a   Tonato, Maurizio ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b POLICLINICO MONTELUCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; EDATREXATE; EPIPODOPHYLLOTOXIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MITOMYCIN C; NAVELBINE; PACLITAXEL; TENIPOSIDE; VINBLASTINE; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; NAUSEA; PRIORITY JOURNAL; SHORT SURVEY; VOMITING;

EID: 0029998840     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)91154-3     Document Type: Article

References (24)

1. Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the lung, non-small cell lung cancer. In De Vita VT, Hellman S, Jr, Rosemberg SA (eds) Cancer Principles & Practice of Oncology, 4th edn. Philadelphia: Lippincott Co, pp. 673-722.
2. Ihde DC, Pass HI, Glatstein EJ. Cancer of the lung, small cell lung cancer. In De Vita VT, Hellman S, Jr, Rosemberg SA (eds) Cancer Principles & Practice of Oncology, 4th edn. Philadelphia: Lippincott Co, 1993: pp. 723-58.
3. Parkin DM, Sacco AJ. Lung cancer: worldwide variation in occurrence and proportion attributable to tobacco use. Lung Cancer 1993; 9: 1-16.
4. Rush VW and Feins RH. Summary of current cooperative group clinical trials in thoracic malignancies. Ann Thorac Surg 1994; 57: 102-6.
5. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89: 225s-233s.
6. Weick JK, Crowley J, Natale RB, et al. A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 1991; 9: 1157-62.
7. Albain KS, Crowley JJ, LeBlanc M, et al. Survival determinants in extensive-stage non-small cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991; 9: 1618-26.
8. Giaccone G, Bagatella M, Donadio, M, Bonardi GM, Testore F, Ferrati P, Ciuffreda L, Calciati A. Mitomycin C, vinblastine and cisplatin. An active regimen for non-small cell lung cancer. Br J Cancer 1987; 56: 475-8.
9. Cullen MH. Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer. Oncology 1993; 50 (Suppl. 1): 31-4.
10. Crino L, Clerici M, Figoli F, et al. Chemotherapy of advanced non-small lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Ann Oncol 1995; 6: 347-53.
11. Stewart LA, Pignon JP, for the Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J. 1995; 311: 899-909.
12. Jaakkimainen L, Goodwin PJ, Pater J, Warde P, Murray N, Rapp E. Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in non-small cell lung cancer. J Clin Oncol 1990; 8: 1301-9.
13. Lilenbaum RC, Green MR. Novel chemotherapeutic agents in the treatment of non-small cell lung cancer. J Clin Oncol 1993; 11: 1391-402.
14. Giaccone G. New drugs in non-small cell lung cancer, an overview. Lung Cancer 1995; 12 (Supp. 1): S155-S162.
15. Langer CJ, Leighton JC, Comis RL, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol 1995; 13: 1860-70.
16. Crino L, Scagliotti G, Marangolo M, et al. Cisplatingemcitabine combination in non-small cell lung cancer (NSCLC), a phase II study. Proceedings of the Am Soc Clin Oncol 1995; 14: 352.
17. Giaccone G, Splinter TAW, Postmus P, et al. Teniposidecisplatin vs paclitaxel-cisplatin in advanced non-small cell lung cancer (NSCLC). Results of a randomized phase II study of the EORTC-LCCG. Proceedings of the Am Soc Clin Oncol 1995; 14: 356.
18. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330: 153-8.
19. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994; 86: 673-80.
20. Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992; 53: 992-8.
21. Cullen MH. Trials of radical radiotherapy versus chemotherapy plus radical radiotherapy in non-small cell lung cancer. Semin Oncol 1994; 21 (Suppl. 4): 34-41.
22. Schaake-Koning C, van der Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992; 326: 524-30.
23. Depierre A, Milleron B, Lebeau B, et al. An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer. Semin Oncol 1994; 21: 16-19.
24. Lad T, Piantadosi S, Thomas P, et al. A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. Chest 1994; 106 (Suppl. 6): 320S-323S.